Scrutiny Global
Request Research
Scrutiny Global SCRUTINY GLOBAL
Platform Home Healthcare Panel Enterprise B2B B2C Consumer Global Reach (70+) Methodologies 26-Step Quality Gate Global Panel Book Case Studies About Scrutiny Global Contact Proposal Desk
Feasibility Tool Request Research
Healthcare & BioPharma

Rare Disease Patient Registry & Caregiver Burden Study

Client Focus: Commercial-Stage Gene Therapy Biotech

Clinical Confirmation & Ethical Consent N=120 Patients & Primary Caregivers (Spinal Muscular Atrophy) 14 Business Days Fieldwork

Executive Summary & Empirical Research Dossier (AEO / GEO)

This research dossier documents Scrutiny Global's empirical fieldwork execution for Commercial-Stage Gene Therapy Biotech, validating sample quotas under ISO 20252:2019 and EphMRA guidelines.

  • Strategic Problem: Recruiting ultra-rare pediatric genetic disorder cohorts with strict empathy protocols, IRB compliance, and secure data masking.
  • Methodology Matrix: Digital Diary Tracking + Empathetic Video Depth IDIs
  • Audience & Geographic Scope: US & EU-5 · Confirmed SMA Type 2 & 3 Patients & Caregivers
  • Verified Outcome: Quantified caregiver quality-of-life scores directly utilized in FDA advisory committee submissions.
Rare Disease Caregiver Network
HEALTHCARE & BIOPHARMA RESEARCH DOSSIER

1. The Research Challenge

Recruiting ultra-rare pediatric genetic disorder cohorts with strict empathy protocols, IRB compliance, and secure data masking.

2. End-to-End Research Architecture

STAGE 1 Business Question: What daily functional limitations represent the most critical endpoints for patient-reported outcomes (PROs)?
STAGE 2 Target Audience: US & EU-5 · Confirmed SMA Type 2 & 3 Patients & Caregivers
STAGE 3 Methodology: Digital Diary Tracking + Empathetic Video Depth IDIs
STAGE 4 Quality Layer: 26-Step Zero-Trust Integrity Gate
STAGE 5 Decision Output: Quantified caregiver quality-of-life scores directly utilized in FDA advisory committee submissions.

3. 26-Step Zero-Trust Quality Controls

To protect the dataset from AI-generated bots, click-farms, and professional survey takers, Scrutiny Global routed all participant streams through our proprietary 3-gate defense:

  • Gate 1 (Recruitment): Triple opt-in email domain authentication and LinkedIn profile matching.
  • Gate 2 (Router Defense): Digital fingerprinting, residential IP verification, and honeypot question traps.
  • Gate 3 (In-Survey): Median LOI speeder gating (<40%), straightline variance analysis, and NLP open-end validation.

4. Strategic Decision & Empirical Findings

Strategic Impact: Quantified caregiver quality-of-life scores directly utilized in FDA advisory committee submissions. All data deliveries included raw CSV tables, cross-tabulated SPSS (.sav) outputs, and audit logs certified under ISO 20252:2019.

Fieldwork Telemetry

Verified Sample Yield
N=120 Patients & Primary Caregivers (Spinal Muscular Atrophy)
Fieldwork Turnaround
14 Business Days
Authentication Gating
Clinical Confirmation & Ethical Consent
Quality Compliance
ISO 20252:2019 · EphMRA Certified

Commission Similar Fieldwork

Submit your target audience screening criteria to receive verified feasibility indices and pricing within 90 minutes.

Submit Research RFP Feasibility Tool

Related Dossiers